Reprogramming human B cells with custom heavy-chain antibodies is a research paper published in Nature Biomedical Engineering (2024). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Health & Human Services | National Institutes of Health
Grant: AI164561
U.S. Department of Health & Human Services | National Institutes of Health
Grant: AI164556
U.S. Department of Health & Human Services | National Institutes of Health
Grant: MH130178
U.S. Department of Health & Human Services | National Institutes of Health
Grant: HL156274
National Institutes of Health
Grant: 5R01HL156274-02
JMJD3 Regulates Abdominal Aortic Aneurysm Expansion
National Institutes of Health
Grant: 5R01HL164561-02
Cardiovascular Health of Low-Income Working-Age Adults in the US: Health Care Access, Policy, and the Pandemic
National Institutes of Health
Grant: 5UM1AI164561-03
Reversing Immune Dysfunction for HIV-1 Eradication
National Institutes of Health
Grant: 1R21MH130178-01
Gene edited B cells to co-express CNS-targeted antibodies
National Institutes of Health
Grant: 3P30CA014089-17S1
USC COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
National Institutes of Health
Grant: 5UM1AI164556-02
I4C 2.0: Immunotherapy for Cure
FWCI
1.97
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals